215 related articles for article (PubMed ID: 35902393)
21. Prognostic implications of body composition change during primary treatment in patients with ovarian cancer: A retrospective study using an artificial intelligence-based volumetric technique.
Kim SI; Yoon S; Kim TM; Cho JY; Chung HH; Song YS
Gynecol Oncol; 2021 Jul; 162(1):72-79. PubMed ID: 33994146
[TBL] [Abstract][Full Text] [Related]
22. Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer.
Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Yao S; Yagi S; Kamo N; Hatano E; Okajima H; Takaori K; Uemoto S
Ann Surg Oncol; 2017 Nov; 24(12):3732-3740. PubMed ID: 28871520
[TBL] [Abstract][Full Text] [Related]
23. Skeletal muscle wasting and long-term prognosis in patients undergoing rectal cancer surgery without neoadjuvant therapy.
Giani A; Famularo S; Fogliati A; Riva L; Tamini N; Ippolito D; Nespoli L; Braga M; Gianotti L
World J Surg Oncol; 2022 Feb; 20(1):51. PubMed ID: 35216606
[TBL] [Abstract][Full Text] [Related]
24. Obesity may not be related to pathologic response in locally advanced rectal cancer following neoadjuvant chemoradiotherapy.
Bao QR; Crimì F; Valotto G; Chiminazzo V; Bergamo F; Prete AA; Galuppo S; El Khouzai B; Quaia E; Pucciarelli S; Urso EDL
Front Oncol; 2022; 12():994444. PubMed ID: 36249024
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of preoperative CT scan derived body composition measures in resected pancreatic cancer.
Guarneri G; Pecorelli N; Bettinelli A; Campisi A; Palumbo D; Genova L; Gasparini G; Provinciali L; Della Corte A; Abati M; Aleotti F; Crippa S; De Cobelli F; Falconi M
Eur J Surg Oncol; 2024 May; 50(5):106848. PubMed ID: 36863915
[TBL] [Abstract][Full Text] [Related]
26. Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer.
Slaughter KN; Thai T; Penaroza S; Benbrook DM; Thavathiru E; Ding K; Nelson T; McMeekin DS; Moore KN
Gynecol Oncol; 2014 Apr; 133(1):11-5. PubMed ID: 24680585
[TBL] [Abstract][Full Text] [Related]
27. Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.
Kamo N; Kaido T; Hamaguchi Y; Okumura S; Kobayashi A; Shirai H; Yao S; Yagi S; Uemoto S
Clin Nutr; 2019 Oct; 38(5):2202-2209. PubMed ID: 30482562
[TBL] [Abstract][Full Text] [Related]
28. Visceral and subcutaneous fat as new independent predictive factors of survival in locally advanced gastric carcinoma patients treated with neo-adjuvant chemotherapy.
Li XT; Tang L; Chen Y; Li YL; Zhang XP; Sun YS
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1237-47. PubMed ID: 25537963
[TBL] [Abstract][Full Text] [Related]
29. Is sarcopenia a better predictor of complications than body mass index? Sarcopenia and surgical outcomes in patients with rectal cancer.
Jochum SB; Kistner M; Wood EH; Hoscheit M; Nowak L; Poirier J; Eberhardt JM; Saclarides TJ; Hayden DM
Colorectal Dis; 2019 Dec; 21(12):1372-1378. PubMed ID: 31276286
[TBL] [Abstract][Full Text] [Related]
30. Association between specific presurgical anthropometric indexes and morbidity in patients undergoing rectal cancer resection.
Giani A; Famularo S; Riva L; Tamini N; Ippolito D; Nespoli L; Conconi P; Sironi S; Braga M; Gianotti L
Nutrition; 2020; 75-76():110779. PubMed ID: 32268263
[TBL] [Abstract][Full Text] [Related]
31. Body Composition in Relation to Clinical Outcomes in Renal Cell Cancer: A Systematic Review and Meta-analysis.
Vrieling A; Kampman E; Knijnenburg NC; Mulders PF; Sedelaar JPM; Baracos VE; Kiemeney LA
Eur Urol Focus; 2018 Apr; 4(3):420-434. PubMed ID: 28753824
[TBL] [Abstract][Full Text] [Related]
32. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
[TBL] [Abstract][Full Text] [Related]
33. Three different computed tomography obesity indices, two standard methods, and one novel measurement, and their association with outcomes after colorectal cancer surgery.
Frostberg E; Pedersen MR; Manhoobi Y; Rahr HB; Rafaelsen SR
Acta Radiol; 2021 Feb; 62(2):182-189. PubMed ID: 32338034
[TBL] [Abstract][Full Text] [Related]
34. An increasing proportion of perinephric to subcutaneous fat is associated with adverse perioperative outcomes of robotic partial nephrectomy.
Raman JD; Reynolds C; Hannon M
J Robot Surg; 2016 Sep; 10(3):255-9. PubMed ID: 27160676
[TBL] [Abstract][Full Text] [Related]
35. Visceral obesity, muscle mass and outcome in rectal cancer surgery after neo-adjuvant chemo-radiation.
Heus C; Cakir H; Lak A; Doodeman HJ; Houdijk AP
Int J Surg; 2016 May; 29():159-64. PubMed ID: 27063857
[TBL] [Abstract][Full Text] [Related]
36. Visceral fat area, not body mass index, predicts postoperative 30-day morbidity in patients undergoing colon resection for cancer.
Kuritzkes BA; Pappou EP; Kiran RP; Baser O; Fan L; Guo X; Zhao B; Bentley-Hibbert S
Int J Colorectal Dis; 2018 Aug; 33(8):1019-1028. PubMed ID: 29658059
[TBL] [Abstract][Full Text] [Related]
37. Utilizing quantitative measures of visceral adiposity in evaluating trauma patient outcomes.
Docimo S; Lamparello B; Cohen MF; Kopatsis A; Vinces F
Int J Surg; 2015 Sep; 21():51-6. PubMed ID: 26166742
[TBL] [Abstract][Full Text] [Related]
38. Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer.
van Dijk DP; Bakens MJ; Coolsen MM; Rensen SS; van Dam RM; Bours MJ; Weijenberg MP; Dejong CH; Olde Damink SW
J Cachexia Sarcopenia Muscle; 2017 Apr; 8(2):317-326. PubMed ID: 27897432
[TBL] [Abstract][Full Text] [Related]
39. Quantitative assessment of mesorectal fat: new prognostic biomarker in patients with mid-to-lower rectal cancer.
Yoon J; Chung YE; Lim JS; Kim MJ
Eur Radiol; 2019 Mar; 29(3):1240-1247. PubMed ID: 30229270
[TBL] [Abstract][Full Text] [Related]
40. High visceral fat-to-muscle ratio is an independent factor that predicts worse overall survival in patients with primary epithelial ovarian, fallopian tube, and peritoneal cancer.
Ham S; Choi JH; Shin SG; Lee EJ
J Ovarian Res; 2023 Jan; 16(1):19. PubMed ID: 36681847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
